@article{
 title = {Psychedelics and Personality},
 type = {article},
 year = {2018},
 identifiers = {[object Object]},
 keywords = {Psychedelics,anxiety,hallucinogens,mood,personality,substance abuse},
 pages = {acschemneuro.8b00237},
 websites = {http://pubs.acs.org/doi/10.1021/acschemneuro.8b00237},
 month = {6},
 publisher = {American Chemical Society},
 day = {4},
 id = {1e73c3a4-5356-3601-bc1a-a3960126343e},
 created = {2018-06-12T11:46:57.755Z},
 accessed = {2018-06-09},
 file_attached = {false},
 profile_id = {38c6dbcb-2394-3f18-9217-58d777c08c69},
 group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},
 last_modified = {2019-10-23T13:46:50.112Z},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {true},
 hidden = {false},
 citation_key = {Aixala2018},
 notes = {RK},
 private_publication = {false},
 abstract = {In the past decade, an increasing number of clinical trials are reporting evidence that psychedelics or serotonergic hallucinogens (such as lysergic acid diethylamide, psilocybin, and ayahuasca/dimethyltryptamine) could be effective in the treatment of mood, anxiety, and substance use disorders. The mechanisms responsible for these effects are not fully understood but seem to involve changes in bran dynamics in areas rich in serotonergic 5-HT2A receptors and in personality. In the present text, we present a brief and critical overview of the current research in this field, pointing out both promises and limitations of these studies.},
 bibtype = {article},
 author = {Aixalá, Marc and dos Santos, Rafael Guimarães and Hallak, Jaime Eduardo Cecilio and Bouso, José Carlos},
 journal = {ACS Chemical Neuroscience}
}

{"_id":"7dRB9ScMtcEgGkiNZ","bibbaseid":"aixal-dossantos-hallak-bouso-psychedelicsandpersonality-2018","downloads":0,"creationDate":"2018-07-20T08:07:38.876Z","title":"Psychedelics and Personality","author_short":["Aixalá, M.","dos Santos, R., G.","Hallak, J., E., C.","Bouso, J., C."],"year":2018,"bibtype":"article","biburl":null,"bibdata":{"title":"Psychedelics and Personality","type":"article","year":"2018","identifiers":"[object Object]","keywords":"Psychedelics,anxiety,hallucinogens,mood,personality,substance abuse","pages":"acschemneuro.8b00237","websites":"http://pubs.acs.org/doi/10.1021/acschemneuro.8b00237","month":"6","publisher":"American Chemical Society","day":"4","id":"1e73c3a4-5356-3601-bc1a-a3960126343e","created":"2018-06-12T11:46:57.755Z","accessed":"2018-06-09","file_attached":false,"profile_id":"38c6dbcb-2394-3f18-9217-58d777c08c69","group_id":"d9389c6c-8ab5-3b8b-86ed-33db09ca0198","last_modified":"2019-10-23T13:46:50.112Z","read":false,"starred":false,"authored":false,"confirmed":"true","hidden":false,"citation_key":"Aixala2018","notes":"RK","private_publication":false,"abstract":"In the past decade, an increasing number of clinical trials are reporting evidence that psychedelics or serotonergic hallucinogens (such as lysergic acid diethylamide, psilocybin, and ayahuasca/dimethyltryptamine) could be effective in the treatment of mood, anxiety, and substance use disorders. The mechanisms responsible for these effects are not fully understood but seem to involve changes in bran dynamics in areas rich in serotonergic 5-HT2A receptors and in personality. In the present text, we present a brief and critical overview of the current research in this field, pointing out both promises and limitations of these studies.","bibtype":"article","author":"Aixalá, Marc and dos Santos, Rafael Guimarães and Hallak, Jaime Eduardo Cecilio and Bouso, José Carlos","journal":"ACS Chemical Neuroscience","bibtex":"@article{\n title = {Psychedelics and Personality},\n type = {article},\n year = {2018},\n identifiers = {[object Object]},\n keywords = {Psychedelics,anxiety,hallucinogens,mood,personality,substance abuse},\n pages = {acschemneuro.8b00237},\n websites = {http://pubs.acs.org/doi/10.1021/acschemneuro.8b00237},\n month = {6},\n publisher = {American Chemical Society},\n day = {4},\n id = {1e73c3a4-5356-3601-bc1a-a3960126343e},\n created = {2018-06-12T11:46:57.755Z},\n accessed = {2018-06-09},\n file_attached = {false},\n profile_id = {38c6dbcb-2394-3f18-9217-58d777c08c69},\n group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},\n last_modified = {2019-10-23T13:46:50.112Z},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {true},\n hidden = {false},\n citation_key = {Aixala2018},\n notes = {RK},\n private_publication = {false},\n abstract = {In the past decade, an increasing number of clinical trials are reporting evidence that psychedelics or serotonergic hallucinogens (such as lysergic acid diethylamide, psilocybin, and ayahuasca/dimethyltryptamine) could be effective in the treatment of mood, anxiety, and substance use disorders. The mechanisms responsible for these effects are not fully understood but seem to involve changes in bran dynamics in areas rich in serotonergic 5-HT2A receptors and in personality. In the present text, we present a brief and critical overview of the current research in this field, pointing out both promises and limitations of these studies.},\n bibtype = {article},\n author = {Aixalá, Marc and dos Santos, Rafael Guimarães and Hallak, Jaime Eduardo Cecilio and Bouso, José Carlos},\n journal = {ACS Chemical Neuroscience}\n}","author_short":["Aixalá, M.","dos Santos, R., G.","Hallak, J., E., C.","Bouso, J., C."],"urls":{"Website":"http://pubs.acs.org/doi/10.1021/acschemneuro.8b00237"},"bibbaseid":"aixal-dossantos-hallak-bouso-psychedelicsandpersonality-2018","role":"author","keyword":["Psychedelics","anxiety","hallucinogens","mood","personality","substance abuse"],"downloads":0},"search_terms":["psychedelics","personality","aixalá","dos santos","hallak","bouso"],"keywords":["psychedelics","anxiety","hallucinogens","mood","personality","substance abuse"],"authorIDs":[]}